Wave Life Sciences, Inc. (WVE)
NASDAQ: WVE · Real-Time Price · USD
5.04
-0.12 (-2.33%)
At close: Aug 28, 2026, 4:00 PM EDT
5.09
+0.05 (1.07%)
After-hours: Aug 28, 2026, 7:59 PM EDT
Wave Life Sciences Revenue
Wave Life Sciences had revenue of $2.27M in the quarter ending June 30, 2026, a decrease of -73.88%. This brings the company's revenue in the last twelve months to $65.37M, down -30.42% year-over-year. In the year 2025, Wave Life Sciences had annual revenue of $42.73M, down -60.55%.
Revenue (ttm)
$65.37M
Revenue Growth
-30.42%
P/S Ratio
15.19
Revenue / Employee
$206,218
Employees
317
Market Cap
993.12M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 42.73M | -65.58M | -60.55% |
| Dec 31, 2024 | 108.30M | -5.00M | -4.42% |
| Dec 31, 2023 | 113.31M | 109.66M | 3,005.10% |
| Dec 31, 2022 | 3.65M | -37.32M | -91.09% |
| Dec 31, 2021 | 40.96M | 20.89M | 104.03% |
| Dec 31, 2020 | 20.08M | 4.09M | 25.61% |
| Dec 31, 2019 | 15.98M | 1.57M | 10.89% |
| Dec 31, 2018 | 14.41M | 10.52M | 270.25% |
| Dec 31, 2017 | 3.89M | 2.80M | 256.50% |
| Dec 31, 2016 | 1.09M | 940.00K | 618.42% |
| Dec 31, 2015 | 152.00K | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ardelyx | 450.89M |
| Geron | 204.56M |
| Arbutus Biopharma | 181.72M |
| Lexicon Pharmaceuticals | 41.47M |
| Inventiva | 7.94M |
| Avalo Therapeutics | 59.00K |
WVE News
- 18 days ago - Wave Life Sciences Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 19 days ago - Wave Life Sciences Transcript: Bank of America SMID Cap Virtual Conference - Transcripts
- 20 days ago - Wave Life Sciences announces completion of redomiciliation to Delaware - TheFly
- 20 days ago - Wave Life Sciences Announces Completion of Redomiciliation to Delaware - GlobeNewsWire
- 25 days ago - Wave Life Sciences Announces Expected Completion Date for Redomiciliation to Delaware - GlobeNewsWire
- 26 days ago - Wave Life Sciences to Present at Upcoming Investor Conferences - GlobeNewsWire
- 26 days ago - Wave Life Sciences price target lowered to $23 from $27 at Mizuho - TheFly
- 4 weeks ago - Wave Life Sciences price target raised to $22 from $21 at B. Riley - TheFly